Status:
COMPLETED
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Lead Sponsor:
Glaukos Corporation
Conditions:
Primary Open-angle Glaucoma
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
Evaluate the safety and efficacy of the Glaukos® Suprachoroidal Stent Model G3 in conjunction with cataract surgery, compared to cataract surgery only, in subjects with mild to moderate primary open-a...
Detailed Description
This is an IDE trial to evaluate the safety and efficacy of the Glaukos® Suprachoroidal Stent Model G3 (hereinafter referred to as G3) in conjunction with cataract surgery, compared to cataract surger...
Eligibility Criteria
Inclusion
- Mild to moderate open-angle glaucoma
- Characteristics consistent with mild to moderate glaucoma
- Use of one (1) to three (3) medications at time of screening exam
Exclusion
- Pigmentary or pseudoexfoliative glaucoma
- Prior incisional glaucoma surgery
Key Trial Info
Start Date :
December 22 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2020
Estimated Enrollment :
505 Patients enrolled
Trial Details
Trial ID
NCT01461278
Start Date
December 22 2011
End Date
March 12 2020
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Centers of Racine and Kenosha
Racine, Wisconsin, United States, 53405